Who is sponsoring NCT03626298?

NCT03626298 is sponsored by Rumah Sakit Pusat Angkatan Darat Gatot Soebroto.

What condition does NCT03626298 study?

NCT03626298 studies Acne Vulgaris.

What drugs are being tested in NCT03626298?

Interventions: Adapalene, Nicotinamide, ABA and Zinc PCA, Placebos.

What is the status of NCT03626298?

NCT03626298 is currently COMPLETED.

Last reviewed 2018-08-13 · How we verify

Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia

NCT03626298 PHASE4 COMPLETED

Acne vulgaris (AV) is a chronic inflammatory disease of the pilosebaceous unit that affects seborrheic areas such as the face, back and chest. AV is characterized by blackheads, papules, pustules nodes and cysts with sequelae of hyperpigmentation and scarring. It is one of the most common skin disorders treated by dermatologists. Acne vulgaris can be found at any age, although it is more frequent in teenagers and young adults. The prevalence of AV in a population of 11 to 30 years old is approximately 80%. Due to its involvement of the face, it is considered to be a cosmetic problem, thus bearing a psychosocial burden.

Details

Lead sponsor	Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Phase	PHASE4
Status	COMPLETED
Enrolment	125
Start date	Mon Aug 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Apr 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Acne Vulgaris

Interventions

Adapalene
Nicotinamide, ABA and Zinc PCA
Placebos